Adel Arezki
Papers
3
Total Citations
34
H-Index
3
About
Adel Arezki is a urological researcher whose work focuses on improving outcomes for prostate cancer patients through precision diagnostics and postoperative care. His key research areas include prostate volume estimation, oncological safety of hormone therapies, and functional recovery after robotic-assisted radical prostatectomy (RARP). In his highly cited 2021 study (17 citations), Arezki evaluated the accuracy of handheld wireless point-of-care ultrasound—comparing transabdominal and transrectal approaches—against radical prostatectomy specimen weights, demonstrating a practical, non-invasive method for preoperative prostate morphology assessment. He also contributed to the critical debate on testosterone replacement therapy in hypogonadal prostate cancer survivors, showing its oncological safety and functional benefits post-RARP (14 citations). Additionally, his age-stratified analysis of continence outcomes after RARP (2022) provides valuable insights into recovery expectations for Canadian men, helping tailor postoperative counseling. With a growing citation impact, Arezki’s work bridges technological innovation and patient-centered care, advancing both diagnostic accuracy and quality of life in urological oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3